Marco Vecchia
Directeur/Membre du Conseil chez Cheshire Healthcare Ltd.
Profil
Marco Vecchia is a Director at Chiesi España SA, Chiesi Pharmaceuticals BV, Chiesi Hellas Pharmaceuticals SA, Opocrin SpA, Chiesi Ltd., Chiesi Healthcare Ltd., Chiesi International Holding BV, Cheshire Healthcare Ltd., Opocrin SRL, Novadynamics Healthcare Srl, Chiesi Pharmaceuticals (Pvt) Ltd., Chiesi Pharmaceuticals, Inc., Chiesi Pharmaceuticals Shanghai Co. Ltd., Chiesi SA (Belgium), and Amryt Pharma Holdings Ltd.
He is also the Head-Legal and Corporate Affairs at CHIESI Farmaceutici SpA.
Mr. Vecchia previously worked as a Director at Cornerstone Therapeutics, Inc. and Chiesi SAS.
He graduated from the University of Parma.
Postes actifs de Marco Vecchia
| Sociétés | Poste | Début |
|---|---|---|
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Conseiller Juridique Général | - |
| Cheshire Healthcare Ltd. | Directeur/Membre du Conseil | 06/05/2010 |
Chiesi Ltd.
 Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom. | Directeur/Membre du Conseil | 06/05/2010 |
| Chiesi Healthcare Ltd. | Directeur/Membre du Conseil | 06/05/2010 |
Chiesi Hellas Pharmaceuticals SA
 Chiesi Hellas Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Chiesi Hellas Pharmaceuticals SA provides research, development and sale of medicinal products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It offers solutions for the treatment of asthma and chronic obstructive pulmonary disease. The company is headquartered in Vrilissa, Greece. | Directeur/Membre du Conseil | 06/05/2010 |
| Chiesi International Holding BV | Directeur/Membre du Conseil | 06/05/2010 |
Chiesi Pharmaceuticals BV
 Chiesi Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Chiesi Pharmaceuticals BV provides research, development and sale of medical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company is headquartered in Rijswijk, the Netherlands. | Directeur/Membre du Conseil | 06/05/2010 |
Opocrin SpA
 Opocrin SpA Pharmaceuticals: MajorHealth Technology Opocrin SpA engages in the manufacture and marketing of active ingredients for the pharmaceutical industry. Its products include Collagen Gel, Sodium and Calcium Heparin, Iron Complexes, Parnaparin, and Pulmonary Surfactant. The company was founded by Pietro Bianchini in 1964 and is headquartered in Modena, Italy. | Directeur/Membre du Conseil | 06/05/2010 |
| Opocrin SRL | Directeur/Membre du Conseil | 06/05/2010 |
| ░░░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Marco Vecchia
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Marco Vecchia
| University of Parma | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Health Technology |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
| Cheshire Healthcare Ltd. | |
Chiesi Ltd.
Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom. | Electronic Technology |
| Chiesi Healthcare Ltd. | |
Chiesi SAS
 Chiesi SAS Pharmaceuticals: GenericHealth Technology Chiesi SAS wholesales and distributes pharmaceutical products. The company was founded in 1992 and is headquartered in Bois-Colombes, France. | Health Technology |
Chiesi Hellas Pharmaceuticals SA
Chiesi Hellas Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Chiesi Hellas Pharmaceuticals SA provides research, development and sale of medicinal products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It offers solutions for the treatment of asthma and chronic obstructive pulmonary disease. The company is headquartered in Vrilissa, Greece. | Health Technology |
| Chiesi International Holding BV | |
Chiesi Pharmaceuticals BV
Chiesi Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Chiesi Pharmaceuticals BV provides research, development and sale of medical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company is headquartered in Rijswijk, the Netherlands. | Health Technology |
Opocrin SpA
Opocrin SpA Pharmaceuticals: MajorHealth Technology Opocrin SpA engages in the manufacture and marketing of active ingredients for the pharmaceutical industry. Its products include Collagen Gel, Sodium and Calcium Heparin, Iron Complexes, Parnaparin, and Pulmonary Surfactant. The company was founded by Pietro Bianchini in 1964 and is headquartered in Modena, Italy. | Health Technology |
| Opocrin SRL | |
| Novadynamics Healthcare SRL | |
| Chiesi Pharmaceuticals (Pvt) Ltd. | |
| Chiesi Pharmaceuticals, Inc. | |
Chiesi España SA
 Chiesi España SA Pharmaceuticals: MajorHealth Technology Chiesi España SA manufactures and distributes pharmaceutical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation, and neonatology. The firm produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It also provides solutions for the treatment of asthma and chronic obstructive pulmonary diseases. The company is headquartered in Barcelona, Spain. | Health Technology |
| Chiesi Pharmaceuticals Shanghai Co. Ltd. | |
Chiesi SA (Belgium)
 Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi. | Health Technology |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
